ValueQ3, 24Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMSelling/general/admin expenses56.65 M62.34 M57.37 M65.72 M69.46 M91.72 M284.27 MResearch & development84.61 M93.63 M99.84 M112.55 M99.23 M104.4 M416.03 MOperating income-140.8 M-139.04 M-155.63 M-111.51 M-166.75 M178.37 M-255.53 MNon-Operating Income, Total17.05 M15.01 M13.7 M13 M10.25 M11.47 M48.42 MInterest expense, net of interest capitalized8.93 M8.94 M8.87 M11.08 M11.35 M8.94 M—Non-Operating Income, excl. Interest Expenses8.13 M6.08 M4.83 M1.92 M-1.1 M2.53 M8.18 MUnusual income/expense———————Pretax income157.85 M154.05 M169.33 M124.51 M177 M189.84 M660.68 MEquity in earnings———————Taxes—————300.22 M—Non-controlling/minority interest———————After tax other income/expense———————Net income before discontinued operations160.54 M149.99 M161.4 M134.37 M306.18 M183.03 M784.98 MDiscontinued operations———————Net income160.54 M149.99 M161.4 M134.37 M306.18 M183.03 M784.98 MDilution adjustment———————Preferred dividends———————Diluted net income available to common stockholders160.54 M149.99 M161.4 M134.37 M306.18 M183.03 M784.98 MBasic earnings per share (Basic EPS)-1.36-1.26-1.36-1.13-2.56-1.51-6.56Diluted earnings per share (Diluted EPS)-1.36-1.26-1.36-1.12-2.55-1.51-6.54Average basic shares outstanding109.93 K111.98 K118.5 K118.98 K119.32 K120.1 K476.9 KDiluted shares outstanding109.93 K111.98 K118.5 K118.98 K119.32 K120.1 K476.9 KEBITDA———————EBIT———————Cost of revenue———————Other cost of goods sold———————Depreciation & amortization (cash flow)2.41 M2.38 M2.3 M2.29 M2.68 M2.86 M10.13 M
Cytokinetics Incorporated
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.